+1.25%
Today
Loading 1D prices…
Company profile
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Sector
Industrials
Industry
Laboratory Analytical Instruments
Exchange
Nasdaq
Display currency
USD
Location
LEXINGTON, MA, United States
Employees
171
Fiscal year end
1231
CIK
1380106
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PRPOPrecipio Inc. Common Stock | $48.9M | $24.2M | -1.50% | -$0.23 | +1.52% | Unrated |
| HBIOHarvard Bioscience Inc. Common Stock | $36.6M | $86.6M | -65.51% | -$1.28 | -1.47% | Hold |
| SEERSeer Inc. Class A Common Stock | $108M | $16.6M | -443.96% | -$1.28 | +1.04% | Buy |
| QTRXQuanterix Corporation Common Stock | $121.1M | $138.9M | -77.18% | -$2.51 | +2.20% | Hold |
| NAUTNautilus Biotechnology Inc. Common Stock | $129.8M | $0.00 | — | -$0.47 | +2.53% | Buy |